We are live on ! Find out more
CAG

Crestwood Advisors Group Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.44%
This Fund
S&P 500
This Quarter Est. Return
-6.69%
1 Year Est. Return
+18.44%
3 Year Est. Return
+65.91%
5 Year Est. Return
+80.01%
10 Year Est. Return
+299.27%
AUM
$3.56B
AUM Growth
-$288M
Cap. Flow
+$10.9M
Cap. Flow %
0.31%
Top 10 Hldgs %
31.33%
Holding
311
New
11
Increased
93
Reduced
141
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 23.95%
2 Financials 17.76%
3 Healthcare 10.17%
4 Consumer Discretionary 8.15%
5 Communication Services 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EMR icon
101
Emerson Electric
EMR
$83.3B
$3.81M 0.11%
38,893
+17
+0% +$1.61K
ILCB icon
102
iShares Morningstar US Equity ETF
ILCB
$1.26B
$3.5M 0.1%
55,773
-2,087
-4% -$129K
IWF icon
103
iShares Russell 1000 Growth ETF
IWF
$120B
$3.47M 0.1%
50,028
+936
+2% +$63.9K
CSCO icon
104
Cisco
CSCO
$448B
$3.44M 0.1%
61,650
-767,017
-93% -$43.4M
RTX icon
105
RTX Corp
RTX
$289B
$3.05M 0.09%
30,814
-4,738
-13% -$449K
WFC icon
106
Wells Fargo
WFC
$258B
$3.05M 0.09%
62,937
-549
-0.9% -$29.4K
ESML icon
107
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.83B
$2.97M 0.08%
78,039
+1,397
+2% +$52.7K
IJH icon
108
iShares Core S&P Mid-Cap ETF
IJH
$122B
$2.93M 0.08%
54,595
-1,625
-3% -$86.5K
VWO icon
109
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$2.87M 0.08%
62,245
-7,774
-11% -$374K
JPIN icon
110
JPMorgan Diversified Return International Equity ETF
JPIN
$372M
$2.82M 0.08%
49,982
-31,958
-39% -$1.83M
ORCL icon
111
Oracle
ORCL
$367B
$2.81M 0.08%
33,950
-1,976
-6% -$160K
BSX icon
112
Boston Scientific
BSX
$68.4B
$2.72M 0.08%
61,429
-709
-1% -$30.7K
SHY icon
113
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$2.7M 0.08%
32,380
+988
+3% +$83.5K
MTUM icon
114
iShares MSCI USA Momentum Factor ETF
MTUM
$24.9B
$2.65M 0.07%
15,759
-1,720
-10% -$283K
IBM icon
115
IBM
IBM
$209B
$2.58M 0.07%
19,859
-1,310
-6% -$171K
ABBV icon
116
AbbVie
ABBV
$455B
$2.56M 0.07%
15,785
-1,060
-6% -$154K
RARE icon
117
Ultragenyx Pharmaceutical
RARE
$2.56B
$2.17M 0.06%
29,908
LMT icon
118
Lockheed Martin
LMT
$132B
$1.99M 0.06%
4,506
-15,927
-78% -$6.46M
TMO icon
119
Thermo Fisher Scientific
TMO
$214B
$1.98M 0.06%
3,354
-21
-0.6% -$12.1K
EEM icon
120
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$1.97M 0.06%
43,590
+1,402
+3% +$66.2K
GINN icon
121
Goldman Sachs Innovate Equity ETF
GINN
$204M
$1.89M 0.05%
35,035
-1,148
-3% -$62.3K
GLD icon
122
SPDR Gold Trust
GLD
$133B
$1.82M 0.05%
10,105
-1,595
-14% -$280K
PANW icon
123
Palo Alto Networks
PANW
$265B
$1.81M 0.05%
17,466
+1,620
+10% +$145K
HXL icon
124
Hexcel
HXL
$7.76B
$1.78M 0.05%
30,000
-62
-0.2% -$3.42K
NVDA icon
125
NVIDIA
NVDA
$4.72T
$1.78M 0.05%
65,380
-4,440
-6% -$111K

Similar funds

Crestwood Advisors Group's Q1 2022 Portfolio in Review

As of Q1 2022, Crestwood Advisors Group held 311 positions worth $3.56B, down 7.5% from $3.85B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Crestwood Advisors Group's Q1 2022 filing shows 11 new, 93 increased, 141 reduced and 23 closed positions. Its largest new stake was First Republic Bank: 104,204 shares worth $16.9M. The largest sale was Cisco, an estimated $43.4M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.

  • Crestwood Advisors Group's largest Q1 2022 buy was First Republic Bank: 104,204 shares worth $16.9M.
  • Crestwood Advisors Group added most to iShares Core US Aggregate Bond ETF in Q1 2022, an estimated $15.2M increase.
  • Crestwood Advisors Group's biggest Q1 2022 reduction was Cisco, cutting an estimated $43.4M.
  • Crestwood Advisors Group fully exited Xilinx Inc in Q1 2022, selling an estimated $1.32M.
  • Crestwood Advisors Group's ten largest holdings make up 31% of its $3.56B portfolio in Q1 2022.
  • Crestwood Advisors Group opened 11 new positions and closed 23 in Q1 2022.
  • Crestwood Advisors Group's portfolio value fell 7.5% quarter-over-quarter to $3.56B.

Based on Crestwood Advisors Group's 13F filing for Q1 2022, filed 12 Apr 2022.